MALLORY ANDERSON: Open Payments
NPI 1104166255 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,888 in 95 payments from 20 companies in 2025. Trend: 2023 $1,534 · 2024 $2,301 · 2025 $1,888
Food & beverage: $1,888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $654 |
| Madrigal Pharmaceuticals | 5 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $179 |
| Medtronic, Inc. | 2 | $168 |
| Ardelyx, Inc. | 8 | $145 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| Aimmune Therapeutics, Inc. | 3 | $52 |
| Janssen Biotech, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
Products named: RINVOQ, REZDIFFRA, INTERSTIM, DUPIXENT, XIFAXAN, IBSRELA, SKYRIZI, LINZESS.
Industry payments across SC — which companies pay providers there.
